Tobias Bergenblad
Sales & Marketing chez SCIBASE HOLDING AB (PUBL)
Provenance du réseau au premier degré de Tobias Bergenblad
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Medical Specialties | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tobias Bergenblad via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Director of Finance/CFO | |
elbion NV
 elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
| MEDIGENE AG | Biotechnology | Chief Executive Officer | |
| VITROLIFE AB | Medical Specialties | Chairman Chairman | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer | |
| EPIGENOMICS AG | Medical Specialties | Chief Executive Officer | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SBL Vaccin AB
 SBL Vaccin AB Pharmaceuticals: MajorHealth Technology SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Synectics Medical AB
 Synectics Medical AB Information Technology ServicesTechnology Services Part of Medtronic Plc, Synectics Medical AB is a Swedish company that develops computer support systems for the healthcare industry. The company is based in Stockholm, Sweden. The company was founded by Anders Essen-Möller. Synectics Medical was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on March 11, 1996 for $59 million. | Information Technology Services | Chief Executive Officer Corporate Officer/Principal | |
SEB Venture Capital
 SEB Venture Capital Investment ManagersFinance SEB Venture Capital (SEB Venture Capital) is a venture capital subsidiary of Skandinaviska Enskilda Banken AB founded in 1995. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| University of Uppsala | College/University | Masters Business Admin | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Neoventa Medical AB
 Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member | |
Direct Conversion AB
 Direct Conversion AB Medical SpecialtiesHealth Technology Direct Conversion AB manufactures and supplies X-Ray detectors such as cadmium telluride (CdTe) detectors. Its products include XC-THOR, XC-HYDRA, XC-TDI, XC-ACTAEON, SNAP 225, SNAP 150 and SNAP 100X2. The firm’s products are used in the dental, medical, welding, industrial, food and security industries. The company was founded in 1997 and is headquartered in Danderyd, Sweden. | Medical Specialties | Corporate Officer/Principal | |
| BOULE DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| Technical University of Berlin | College/University | Doctorate Degree | |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Graduate Degree Masters Business Admin | |
| GHP SPECIALTY CARE AB (PUBL) | Medical/Nursing Services | Chairman Chairman | |
| PROMIMIC AB | Medical Specialties | Chairman Corporate Officer/Principal | |
| Racal-Redac, Inc. | Corporate Officer/Principal | ||
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Investment Officer | |
| Siemens-Elema AB | Corporate Officer/Principal | ||
Neoventa Holding AB
 Neoventa Holding AB MiscellaneousMiscellaneous Neoventa Holding AB invests in companies with interests in development and marketing of monitoring and control equipment for perinatal care. The company is headquartered in Molndal, Sweden. | Miscellaneous | Director/Board Member Director/Board Member | |
| Scibase Intressenter AB | Director/Board Member Corporate Officer/Principal Chairman Director/Board Member | ||
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Chairman | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman | |
Pharmacia & Upjohn Co. LLC
 Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia & Upjohn Co. LLC is a company that manufactures and supplies pharmaceutical goods. The company is based in Bingham Farms, MI. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Avidicare AB
 Avidicare AB Medical DistributorsDistribution Services Avidicare AB operates as a medical device company. It specializes in the management of airborne bacteria and virus pollution at hospitals. The firm provides Opragon, a ventilation system for reduction of airborne bacterial contamination in various hospital environments primarily for infection sensitive surgery. The company offers Opragon for preparation rooms, operating theaters, and hybrid rooms; and air curtains and external air showers. Avidicare was founded in 2010 and is headquartered in Lund, Sweden. | Medical Distributors | Director/Board Member | |
| Scibase AB | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member | ||
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Avidicare Holding AB
 Avidicare Holding AB Medical SpecialtiesHealth Technology Avidicare Holding AB provides digital services through its opragon platform and a range of customizable services. Customers can purchase from the Swedish company by contacting their sales directors or CEO, whose contact details are available on their website. | Medical Specialties | Corporate Officer/Principal | |
| Airsonett Holding AB | Director/Board Member | ||
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
| Bluehaven Therapeutics AG | Chief Executive Officer |
Statistiques
Internationale
| Suède | 34 |
| Allemagne | 10 |
| Etats-Unis | 4 |
| Belgique | 3 |
| Finlande | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 5 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 142 |
| Chairman | 59 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 30 |
| Chief Executive Officer | 21 |
Relations les plus connectées
- Bourse
- Insiders
- Tobias Bergenblad
- Connexions Sociétés
